Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: Fifteen-year follow-up

Journal of General Internal Medicine

Volumn 23, Issue 11, 2008, Pages 1809-1814

  Lu Yao, Grace ^a   Albertsen, Peter C ^b   Stanford, Janet L ^c   Stukel, Therese A ^d   Walker Corkery, Elizabeth ^e   Barry, Michael J ^e  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c USA   (United States)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cancer screening; Men's health; Outcomes; Practice variation; Prostate cancer

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

AGE DISTRIBUTION; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; EARLY DIAGNOSIS; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PROSTATE CANCER; PROSTATECTOMY; SCREENING TEST; UNITED STATES;

AGED; CONNECTICUT; FOLLOW-UP STUDIES; HUMANS; MALE; MORTALITY; PHYSICIAN'S PRACTICE PATTERNS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; SEER PROGRAM; WASHINGTON;

EID: 56749163379     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-008-0785-8     Document Type: Article

References (21)

1. Ries L, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute; ; 2006.
2. B Hankey E Feuer L Clegg 1999 Cancer surveillance series: Interpreting trends in prostate cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates J Natl Cancer Inst 91 1017 24
3. E Feuer R Merrill B Hankey 1999 Cancer surveillance series: Interpreting trends in prostate cancer - Part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality J Natl Cancer Inst 91 1025 32
4. R Etzioni DF Penson JM Legler 2002 Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends J Natl Cancer Inst 94 981 90
5. P Shaw R Etzioni S Zeliadt 2004 An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States Am J Epidemiol 160 1059 69
6. A Potosky E Feuer D Levin 2001 Impact of screening on incidence and mortality of prostate cancer in the United States Epidemiologic Reviews 23 181 6
7. P Albertsen 2003 The prostate cancer conundrum J Natl Cancer Inst 95 930 1
8. J Damber 2004 Decreasing mortality rates for prostate cancer: possible role of hormonal therapy BJU International 93 695 701
9. G Lu-Yao PC Albertsen JL Stanford TA Stukel ES Walker-Corkery MJ Barry 2002 Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut BMJ 325 740 5
10. R Smith V Cokkinides H Eyre 2006 American Cancer Society guidelines for the early detection of cancer, 2006 CA Cancer J Clin 56 11 25
11. JU Oleynick PC Albertsen MJ Barry ES Walker-Corkery SL Yao GL Lu-Yao 2006 Utility of the SEER-Medicare data to identify medical androgen deprivation therapy J Clin Onc 24 6113
12. JL Warren CN Klabunde D Schrag PB Bach GF Riley 2002 Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Medical Care 40 IV 3-18
13. McCullagh P, Nelder J. Generalized Linear Models. London: Chapman and Hall; 1989.
14. DR Cox 1972 Regression models and life-tables Journal of the Royal Statistical Society, Series B, Methodological 34 187 220
15. R D'Agostino M Lee A Belanger 1990 Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study Statistics in Medicine 9 1501 15
16. J Concato CK Wells RI Horwitz 2006 The Effectiveness of screening for prostate cancer: A nested case-control study Arch Intern Med 166 38 43
17. W Oberaigner W Horninger H Klocker D Schonitzer W Stuhlinger G Bartsch 2006 Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing Am J Epidemiol 164 376 84
18. Y Wong N Mitra G Hudes 2006 Survival associated with treatment vs observation of localized prostate cancer in elderly men JAMA 296 2683 93
19. G Lu-Yao ER Greenberg 1994 Changes in prostate cancer incidence and treatment in the USA Lancet 343 251 4
20. CJ Newschaffer K Otani MK McDonald LT Penberthy 2000 Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort J Natl Cancer Inst 92 613-
21. A Bill-Axelson L Holmberg M Ruutu 2005 Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 352 1977 84